Wednesday, 26 April 2017

Vivan Life Science Industry in Mumbai, India.


Vivan life science company is one of the best pharmaceutical company in Mumbai, India. It it one of the best life science company. Pharma Company they have their own main unique specific products. Vivan also have own specific product &  Methods like Internal Standard, Analytical Reference Standards, Deuterated Internal Standard, Clinical Diagnostic, HPLC-MS Method Validation, Metabolites, Impurities, LC-MS-MS Method Validation, Quantitative Bioanalytical Methods, Ba Be Studies in Clinical Research, BA/BE Studies etc.


Our company provide best quality products. You can also buy online our products. For more details visit our website and search and select product you want and buy now. Contact us for more details. Our company is also research and Development Company of pharma life science related products.

Monday, 24 April 2017

Ways To Learn Pharmaceutical Life Sciences Company Effectively.



Pharmaceutical Company in Mumbai, India is one of the best company is vivan life science company it is biggest life science company in Thane.  In now days so many pharmaceutical companies are growing step by step. all kind of pharmaceutical as well as chemical companies they have their own products.



Vivan life science company have their own main products like Metabolites, LC-MS-MS Method Validation, Impurities, HPLC-MS Method Validation, Internal Standard etc our company also doing BA/BE Studies and Ba Be Studies in Clinical Research for more details check our website.




Thursday, 20 April 2017

Ways To Introduce Pharmaceutical Company.



Pharma life science is one of the vivan life science company in Mumbai, India. Vivan life science company is big company as well as famous company for pharma life products like Metabolites, Impurities as well as HPLC-MS method validation, BA/BE Studies, Internal Standard, ba be studies in clinical research, Clinical Diagnostic process.


Vivan life science doing Pharmaceutical Research and Development Company.  Our credentials are CRISIL verified, NSIC-CRISIL MSE Rating, CRISIL-SME Ratings, D&B D-U-N-S Number. Check Our Synthesis Lab like R & D Center and Analytics Labs. Check our other products also you can search in our website as well as buy online. 

Tuesday, 18 April 2017

Pharmaceutical Manufacturing & Development Industry Blog


There are so many pharmaceutical and chemical company in Mumbai, India. Vivan life science is one of them. This company is  because this company provide best as well as quality product. These company providing so many pharma products specialty of vivan company are Metabolites, Impurities, BA/BE Studies, Clinical Diagnostic, Internal Standard, LC-MS-MS Method Validation, HPLC-MS Method Validation, Ba Be Studies in Clinical Research etc


Vivan life science have so many sub categories chemical products as well as you can buy also online using add to cart and pay online. Search related your product what you want using search box.




Friday, 13 January 2017

ANDAs Approvals from USFDA

Indian companies received approval for 201 Abbreviated New Drug Application (ANDA) from the United States Food and Drug Administration (FDA) out of total 598 ANDA approvals. Thus, the Indian companies grabbed almost 34 per cent of total final approvals during 2016. Further, out of total 156 tentative approvals, Indian companies secured 70 approvals during 2016 which worked out to 44.9 per cent of total tentative approvals. 

During the last decade US FDA approved 4,666 ANDAs and Indian companies received final approval for 1,524 ANDAs, which worked out to almost 33 per cent. Similarly, total tentative approvals during last decade worked out to 1,101 and out of this Indian companies received 430 tentative approvals, over 39 per cent.

The R&D expenditure of leading 25 Indian Pharma Companies increased by 24 per cent to Rs.11,710 crore during 2015-16 from Rs.9,439 crore in the previous year and these companies established strong presence in highly regulated markets and the same trend is likely to continue in 2016-17. 

Indian companies secured 33.6 per cent of total ANDAs approved by US FDA during 2016. In absolute term Indian companies such as Aurobindo, Glenmark Pharma and Sun Pharma remained as top three companies with higher ANDA approvals.

Aurobindo received highest number of approvals for 58 ANDAs during 2016 followed by Glenmark Pharma 18 ANDAs and Sun Pharma and Taro Pharma also secured 18 ANDA approvals, of which Sun Pharma received 10 ANDA approvals. Lupin grabbed 11 ANDAs. The R&D expenditure of Aurobindo Pharma went up by 23 per cent to Rs.443 crore during 2015-16 from Rs.360 crore in the previous year. Glenmark's R&D spending went up by over 36 per cent to Rs.818 crore from Rs.601 crore and that of Lupin went up by 55 per cent to Rs.1,732 crore. Sun Pharma's R&D expenditure moved up by 17.8 per cent to Rs.2,303 crore from Rs.1955 crore in the previous year. The R&D investment of these companies also increased in the first half of 2016-17.

Among the tentative approvals, Aurobindo received 16 approval followed by Lupin 10, Alkem 6, Strides 5, and Alembic Pharma, Glenmark Pharma and Macleods Pharma 4 each during 2016.